RESUMEN
Ganglioglioma is an uncommon nerves-cell tumour (0.4% of all brain tumours). In 800 brain tumours in children, Garrido et al. (Toronto) found 14 gangliogliomas (1.7%). To our knowledge, ganglioglioma has not been reported in children under 2 1/2 years of age. We have incidentally discovered a ganglioglioma in a 3-day-old girl. Appearance on US, CT and MR are described and discussed.
Asunto(s)
Neoplasias Encefálicas/diagnóstico , Neuroblastoma/diagnóstico , Neoplasias Encefálicas/diagnóstico por imagen , Femenino , Humanos , Recién Nacido , Espectroscopía de Resonancia Magnética , Neuroblastoma/diagnóstico por imagen , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
The mechanisms whereby growth hormone (GH) secretion is decreased in human obesity remain obscure. We studied the response of plasma GH and prolactin (PRL) to an I.V. dose of 0.5 mcg/kg of growth hormone releasing factor (GRF) in three groups of children: lean (N = 12), obese (N = 15) and GRF-deficient, i.e. children with complete GH deficiency on the basis of conventional provocative testing and evidence of hypothalamic dysfunction on the basis of thyrotropin-releasing hormone testing (N = 7). Mean (+/- SEM) peak plasma GH after GRF was blunted to the same extent in obese and in GRF deficient children (11.1 +/- 2.2 and 8.3 +/- 2.8 ng/ml) as compared to lean control children (34.7 +/- 4.7 ng/ml). The pattern of PRL response to GRF was however different in GRF deficient children, whose high basal PRL levels increased further after GRF injection, and in obese and lean children, who had n alpha acute change in PRL levels after GRF. Baseline plasma somatomedin C concentrations were low for age in GRF deficient children and tended to be high for age in obese children. On the basis of these discrepant patterns of response of PRL to GRF and plasma somatomedin C concentrations, we conclude that GRF deficiency does not account for the decreased GH secretion observed in obese children.